December 13, 2019 10:05 AM EST

More questions than answers for biopharma after UK election; Intercept gets FDA advisory date, and a PDUFA delay

ENDPOINTS

→ On Thursday, voters in the UK handed Boris Johnson’s Conservative government, and its aggressive Brexit stance, a clear majority. Urte Jakimaviciute, GlobalData‘s senior director …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

More questions than answers for biopharma after UK election; Intercept gets FDA advisory date, and a PDUFA delay

ENDPOINTS

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

More ques­tions than an­swers for bio­phar­ma af­ter UK elec­tion; In­ter­cept gets FDA ad­vi­so­ry date, and a PDU­FA de­lay

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

More questions than answers for biopharma after UK election; Intercept gets FDA advisory date, and a PDUFA delay